Comparison of neutrophil polycythemia rubra vera-1 (PRV-1) expression among myeloproliferative disorders and in secondary or spurious causes of polycythemia
. | Control . | SP . | ET . | PV . | MMM . |
|---|---|---|---|---|---|
| No. patients, n = 88 | 10 | 22 | 14 | 30 | 12 |
| Total PRF-1/GAPDH | |||||
| ratio ± SD | 1.28 ± 0.07 | 1.23 ± 0.09 | 1.25 ± 0.16 | 1.01 ± 0.13 | 1.21 ± 0.18 |
| Range of ratio | 1.20-1.43 | 0.99-1.41 | 0.90-1.44 | 0.84-1.36 | 0.88-1.4 |
. | Control . | SP . | ET . | PV . | MMM . |
|---|---|---|---|---|---|
| No. patients, n = 88 | 10 | 22 | 14 | 30 | 12 |
| Total PRF-1/GAPDH | |||||
| ratio ± SD | 1.28 ± 0.07 | 1.23 ± 0.09 | 1.25 ± 0.16 | 1.01 ± 0.13 | 1.21 ± 0.18 |
| Range of ratio | 1.20-1.43 | 0.99-1.41 | 0.90-1.44 | 0.84-1.36 | 0.88-1.4 |